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The NR4A is a subfamily of the orphan nuclear receptors (NR) superfamily constituted by three well
characterized members: Nur77 (NR4A1), Nurr1 (NR4A2) and Nor 1 (NR4A3). They are implicated in
numerous biological processes as DNA repair, arteriosclerosis, cell apoptosis, carcinogenesis and
metabolism. Several studies have demonstrated the role of this subfamily on glucose metabolism, insulin
sensitivity and energy balance. These studies have focused mainly in liver and skeletal muscle. However, its
potential role in white adipose tissue (WAT), one of the most important tissues involved in the regulation of
energy homeostasis, is not well-studied. The aim of this work was to elucidate the regulation of NR4A in
WAT under different physiological and pathophysiological settings involved in energy balance such as
fasting, postnatal development, gender, hormonal deficiency and pregnancy. We compared NR4A mRNA
expression of Nur77, Nurr1 and Nor 1 and found a clear regulation by nutritional status, since the
expression of the 3 isoforms is increased after fasting in a leptin-independent manner and sex steroid
hormones also modulate NR4A expression in males and females. Our findings indicate that NR4A are
regulated by different physiological and pathophysiological settings known to be associated with marked
alterations in glucose metabolism and energy status.
I
n addition to its role as an energy reservoir tissue1, the WAT exerts an impact on whole-body metabolism as an
active endocrine organ capable of synthesizing a number of biologically active compounds (adipokines)
regulating metabolic homeostasis. WAT is implicated in the development of several diseases as type II diabetes
and cardiovascular failure2. Furthermore WAT is also essential for the postnatal development, puberty and
fertility3.
The NR4A is a subfamily of orphan nuclear receptors (NR) superfamily that in mammals consists in three
homologous isotypes: Nur77 (NR4A1), Nurr1 (NR4A2) and Nor 1 (NR4A3). NR4A receptors are transcription
factors (contrary to classical ligand active nuclear receptor) whose activity is controlled primarily at the level of
protein expression and/or post-translational modification. The three proteins bind to a specific site called NGFI-
B response element (NRBE: AAAGGTCA) as monomers4,5. These NRs have aminoacid residue homology of 97%
in the DNA-binding domains, 20–30% in the N-terminal transactivation domains and 60–65% in the C-terminal
ligand-binding domain6
NR4A receptors are expressed as early response genes in response to physiological and pathological stimuli
including fatty acids, stress, prostaglandins, growth factors, calcium and inflammatory cytokines, peptide hor-
mones and neurotransmitters7, and are implicated in important biological processes including carcinogenesis/
apoptosis control, inflammation, vascular disease, dopaminergic neuron development and metabolism8.
NR4A are widely expressed in different key metabolic demanding tissues, including skeletal muscle, liver,
WAT and heart9. Most of the studies have focused mainly in the action of NR4As in glucose metabolism in liver
and muscle. The activity of NR4A receptors as transcriptional regulators of glucose metabolism in liver activates
gluconeogenic genes10, enhancing hepatic glucose production and elevating plasma blood glucose. Otherwise
Tontonoźs laboratory found that NR4A expression is induced by cAMP axis10 in response to glucagon and
fasting. In skeletal muscle NR4A is a transcriptional regulator of glycolysis, regulate the expression of genes
related with glucose utilization11, and are implicated in oxidative metabolism and mitochondrial activity12,13.
According with these findings obtained in rodents several human studies have linked obesity and diabetes with
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Although some reports have shown that NR4A is expressed in
WAT and regulates glucose metabolism, almost all of them were
performed in vitro. In 3T3-L1 cells, NR4As are induced by insulin14
and their relation with adipogenesis is controversial, since some
groups did not find any implication of NR4As in adipogenesis17
whereas others demonstrated an inhibition of adipogenesis by
NR4As18. In vivo data of NR4As on WAT are limited to only one
report indicating that Nur77 modulates some of the actions of an a-
MSH (a-melanocyte-stimulating hormone) analog19, suggesting an
important endogenous role for NR4As in WAT metabolism. In this
regard, previous reports have shown that mice lacking Nur77 are
more sensitive to diet-induced obesity, as these mice gain more fat
than the control mice11,20
In spite of these evidences suggesting an important role of NR4As
on adipocytes, the physiological of these receptors in WAT remains
largely unknown.
Therefore, the aim of the present study was to investigate the
regulation of NR4A expression in rat WAT in different physiological
conditions in relation with nutritional status, age and gender, preg-
nancy and hormone deficiency.
Results
Influence of food deprivation, leptin and food composition on
Nur4r expression. First we sought to investigate the effect of food
status on NR4As (Nur77, Nurr1 and Nor-1) mRNA expression in
WAT. We started analyzing the effect of fasting and we found that
after 24 h of fasting there was an increase on mRNA expression for
the 3 studied isotypes of NR4A (Fig 1A). This effect was reverted
when the rats were refed, producing a decrease of mRNA levels until
basal levels similar to those observed in fed ad libitum rats. The leptin
level in this group is represented in Figure 2C.
The next step was to investigate the effect of chronic food restric-
tion (70% of normal intake) along 8, 12, 16 and 21 days. However, we
could not find any significant difference in the NR4As mRNA
expression (Fig. 1B).
After this, and with the reduction of body weight and leptin levels
in the caloric restriction group (Fig. 2A, B) we questioned if the effect
of fasting could be mediated by leptin. For this purpose we used a
mouse model deficient for leptin (Ob). We compared control mice,
ob/ob mice (leptin deficiency) and ob/ob mice treated with leptin and
we failed to observe any difference in the mRNA expression of any of
the isophorms (Fig. 1C).
Finally we analyzed if the diet composition could affect NR4As
expression. We fed rats with standard diet (ND) and with high fat
diet (HFD) during 12 weeks. The HFD produced an increase of
mRNA expression for Nur77 and Nor-1 in WAT, whereas we did
not find any effect on Nurr1.
Influence of age and gender on NR4A mRNA expression. The
WAT has very important implications in postnatal development
and puberty, thereby we analyzed WAT NR4A expression at
different stages of development in males and females.
First we measured mRNA expression at 25, 45, 60 and 90 days
postnatal development in female rats. The expression of mRNA for
Nur77, Nurr1 and Nor-1 increased along all the development with
the highest levels for the 3 isophorms at 90 days postnatal develop-
ment (Fig. 3A). Since at 90 day-old rats are adult and all the gonadal
axis is completely developed, we investigated if sexual hormones
could be implicated in the increase of NR4As mRNA levels. For this
purpose, we used ovariectomized female rats (Fig. 2D) and found
decreased WAT NR4As mRNA expression compared with control
females (sham-operated controls). This data suggests that estrogens
are implicated in the up-regulation of NR4As in the WAT during the
postnatal development in female rats (Fig. 3B).
We next analyzed NR4As mRNA expression at 25, 45, 60 and 90
days of age in male rats and found that similarly to females, the
mRNA expression for the 3 receptors in WAT increased throughout
the development in males with highest levels at 90 days (Fig. 4A). In
order to study the influence of sexual hormones, in this case tes-
tosterone, on NR4As expression, we used gonadectomized males
(Fig. 2D) and found that the lack of gonads decreased NR4As
mRNA expression in WAT compared with control males (sham-
operated controls). This data suggests that testosterone modulates
NR4As levels in WAT (Fig. 4B).
Influence of anterior pituitary hormones. In addition to the assess-
ment of the impact of alterations in the hypothalamus-pituitary-
gonadal axis, we determined whether NR4As mRNA expression
was dependent of alterations in the pituitary function, as these
hormone and/or their targets glands are strongly implicated in the
regulation of energy balance. As thyroid hormones play a crucial role
in the regulation of metabolism, and hypothyroidism produced an
impaired in weigh gain. (Fig. 2E) we analyzed if thyroid hormone
deficiency could affect NR4A levels. Hypothyroidism decreased
mRNA expression of Nur77, Norr1 and Nor-1 in WAT compared
with euthyroids rats (Fig. 5A).
GH (Growth hormone) plays an important role in the control of
metabolic homeostasis such as body composition and glucose and
lipid metabolism21. Thus, we studied the effect of GH deficiency
(dwarf rats) on WAT NR4As levels and found a down-regulation
of Nur77 mRNA expression in GH-deficient rats compared with
controls. The other isotypes, Norr1 and Nor-1, did not present any
difference in the expression in comparison to their controls (Fig. 5B).
Effects of the pregnancy. Finally we decided to analyze NR4A
mRNA expression levels in a special physiological model asso-
ciated to important metabolic and hormonal alterations, which
promote adipose tissue accretion, as is the pregnancy. We analyzed
Nur77, Nurr1 and Nor-1 during different days of gestation (8, 12,16
and 21 days) and we found an increased of Nur77, Nurr1 and Nor-1
mRNA expression for the 3 isophorms in day 8 of gestation, with a
further decrease again from day 12 to 21 until control (non-
pregnant) (Fig. 6).
Discussion
In the present study, we demonstrated that the members of the NR4A
subfamily are regulated in the WAT by different conditions assoc-
iated with metabolic changes such as nutritional status, sex steroids,
pituitary hormones and pregnancy.
Previous reports indicated that NR4As are associated with changes
in fat mass in both rodents and humans. For instance, mice lacking
Nur77 gain more fat when fed a HFD11,20 and Nur77 is a mediator of
fasting-induced Pparc2 regulation in WAT22. The siRNA injection of
Nor-1 in hypothalamus of mice produced a suppression of food
intake and body weight23. In morbid obese patients the expression
of NR4As in the WAT was upregulated when compared to lean
subjects whereas their expression was normalized after fat loss15.
Thereby, we first analyzed the influence of nutritional status (fasting
and chronic food restriction) on NR4As expression. In agreement
with a previous report22 and with data obtained in muscle and liver24,
we found that fasting produced an up-regulation of Nur77 in WAT,
and this effect was reversed when rats returned to the fed status. The
present works demonstrates that these changes were not specific to
Nur77, because Nurr1 and Nor-1 showed an identical profile in the
WAT of fasted and refed rats. Contrary to the findings obtained after
fasting, we failed to detect any significant change in the expression of
NR4As in the WAT of rats challenged to a chronic food restriction.
Thus, our data indicate that NR4As might play an important role in
the metabolic adaptations of the WAT to nutritional status at short-
but not long-term. Furthermore, our results indicate that chronic
food restriction modulates NR4A receptors in a tissue-specific
manner since it was previously demonstrated that NR4As expression
www.nature.com/scientificreports
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Figure 1 | Nutritional status and leptin exert an effect on NR4A1, NR4A2 and NR4A3 mRNA expression in gWAT. (A). Effect of fed ad libitum, 24h-
fasting, and 24 h-refeding on gWAT mRNA expression of NR4A1, NR4A2 and NR4A3 relative to control (Fed). (B). Effect of chronic food restriction
(70%) on gWAT mRNA expression of NR4A1, NR4A2 and NR4A3 relative to control (Fed). (C). Effect of leptin in ob/ob mice on gWAT mRNA
expression of NR4A1, NR4A2 and NR4A3 relative to control (saline). (D). Effect of high fat diet (HFD) on mRNA expression of NR4A1, NR4A2 and
NR4A3 relative to control (Standard diet). Expression of indicated mRNAs was normalized to that of HPRT and the resultant value for each group was
normalized to expression of the target gene in control. Data are expressed as mean 6 SEM (n 5 7–8 animals per group). *p , 0.05; **p , 0.01;
***p , 0,001 vs controls. $$ p , 0,01 vs 24 h-fasting group.
www.nature.com/scientificreports
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Figure 2 | Effects of caloric restriction, fasting, ORX and thyroid status in body weight and leptin levels. (A) Body weight (g) along all the experiment of
rats feed ad libitum or with 8, 12,16 or 21 days of chronic food restriction (70%). (B) Plasma leptin levels (ng/ml) along all the experiment of rats feed
ad libitum or with 8, 12,16 or 21 days of chronic food restriction (70%). (C) Plasma leptin levels (ng/ml) in rats feed ad libitum, 24 h-fasting, and
24 h-refeding. (D) Body weight (g) in control (Sham) and two weeks after orchidectomy (ORX) in males and females rats. (E) Body weight (g) along 21
days of AMT treatment (hypothyroid) and control rats (euthyroid).
www.nature.com/scientificreports
SCIENTIFIC REPORTS | 4 : 4264 | DOI: 10.1038/srep04264 4
was increased in rat skeletal muscle and liver following food
restriction24.
As one of the most important changes in the fasting state is the
decrease of leptin levels, we evaluated whether leptin was mediating
fasting-induced NR4As expression. To test this hypothesis, we ana-
lyzed NR4As expression in leptin deficient (ob/ob) mice treated with
saline or leptin. Although leptin decreased food intake and body
weight (data not shown) we did not find any difference in the
expression of NR4A receptors between control mice and ob/ob mice
with or without leptin. Overall, our results indicate that the effect of
fasting on NR4As expression is independent of leptin. Indeed, fasting
is associated to changes of multiple hormones and factors other than
leptin, so further studies will be necessary the precise mechanism
controlling the expression of NR4S in the WAT after fasting.
Diet-induced obesity (DIO) in rodents represents a robust experi-
mental model of human obesity. Since previous studies demon-
strated that the lack of Nur77 made animals more susceptible to
gain fat when fed a HFD11,20, we next measured NR4As expression
in the WAT of DIO rats. Obese mice exhibit a reduced b-adrenergic
response25 and it was demonstrated that b-adrenergic signaling
induces the expression of mRNAs of NR4As in WAT26.
Unexpectedly, we found that WAT Nur77 and Nor-1 levels were
increased in DIO rats in comparison to lean rats. Although the
explanation for these results is still not clear, it might be possible that
the increased WAT NR4As levels after three months on HFD repre-
sents a compensatory response. Although the regulation of these
receptors in the WAT of obese rodents seems to be quite complex
because WAT NR4As were up-regulated in DIO rats while NR4As
Figure 3 | Postnatal development, age and sex steroids affect NR4A1, NR4A2 and NR4A3 mRNA expression in gWAT of female rats. (A). mRNA
expression of NR4A1, NR4A2 and NR4A3 relative to control (25 days-old rats) during postnatal development in female rats. (B) mRNA expression of
NR4A1, NR4A2 and NR4A3 relative to control (Sham) two weeks after ovariectomy (OVX). Expression of indicated mRNAs was normalized to that of
HPRT and the resultant value for each group was normalized to expression of the target gene in control. Data are expressed as mean 6 SEM (n 5 7–8
animals per group). *p , 0.05; **p , 0.01 vs controls. # p, 0,05 vs 45 days-old rats. $ p , 0,05 vs 60 days-old rats.
www.nature.com/scientificreports
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expression remained unchanged in the WAT of obese ob/ob mice, it
is worthy to note that ob/ob mice exhibit severe endocrine altera-
tions, including hypogonadism, GH deficiency and altered thyroid
hormone levels27, which could differentially modulate NR4As
expression in WAT.
During postnatal development there is a significant accretion of fat
mass in both males and females, which is accompanied by important
changes in the levels of different hormones regulating energy balance
and also insulin resistance28,29. When we measured the expression of
NR4As in WAT of males and females throughout their lifespan, we
found that the mRNA levels of Nur77, Nurr1 and Nor-1 were
increased along development, with the highest levels at 90 days post-
natal in both males and females. These results indicate that the
expression of these receptors in WAT is not affected by gender,
but the age has an important influence on WAT NR4A levels. In this
sense, it is well known that estrogen deficiency in female animals is
associated with hyperphagia, increased body weight and adiposity30
and serum testosterone levels are inversely associated with whole
body and fat mass31. To test the hypothesis that increased Nur77,
Nurr1 and Nor-1 levels were related to sex steroids, we carried out
additional experiments in ovariectomized and orchidectomized rats.
In both cases the absence of endogenous production of sex steroids
(estrogens or testosterone) produced a decrease of WAT Nur77,
Nurr1 and Nor-1 expression, indicating that sex steroids are regu-
lating NR4A expression.
Thyroid hormones and GH are pituitary hormones that play a key
role in the regulation of metabolic homeostasis and adipose tissue
metabolism32. Thyroids hormones (T3 and T4) have been recognized
Figure 4 | Effects of age and sex steroids on NR4A1, NR4A2 and NR4A3 mRNA expression in gWAT of male rats. (A) mRNA expression of NR4A1,
NR4A2 and NR4A3 relative to control (25 days-old rats) during postnatal development in male rats. (B) mRNA expression of NR4A1, NR4A2 and NR4A3
relative to control (Sham) two weeks after gonadectomy (GDX). Expression of indicated mRNAs was normalized to that of HPRT and the resultant
value for each group was normalized to expression of the target gene in control. Data are expressed as mean 6 SEM (n 5 7–8 animals per group).
*p , 0.05; **p , 0.01 versus controls. # p , 0,05 versus 45 days-old rats.
www.nature.com/scientificreports
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as critically important for development, tissue differentiation, and
maintenance of metabolic balance in mammals33. We found
decreased mRNA levels for Nur77, Nurr1 and Nor-1 in the WAT
of hypothyroid rats, suggesting that thyroid hormones are important
modulators of NR4As. Our results also indicate that this regulation is
tissue-specific, because a previous report showed that that Nr4a1 was
increased in both male and female hypothyroid mice34. GH also
influences many metabolic processes, such as body composition
and glucose and lipid metabolism21. We only found a downregulation
in WAT Nur77 expression in dwarf rats when compared to control
rats, whereas the other 2 isoforms remained unchanged. These find-
ings suggest that GH levels differentially modulate these receptors.
Pregnancy is a physiological model characterized by increased
food intake and fat mass35 and during this period there are clear
changes in several mechanisms related to glucose homeostasis36.
Here we found that Nur77, Nurr1 and Nor-1 mRNA levels in
WAT were increased in the first week of gestation but decreased
thereafter returning to levels observed in non-pregnant rats.
Nur77, Nur77 and Nor-1 modulate insulin action and glucose trans-
port in both rodents and humans11,14 and the changes in their WAT
expression occur in the second week of gestation, when the sensitivity
of the maternal tissues for insulin decreases37. Thus, it is possible that
the high NR4A expression in the beginning of the pregnancy and
decreased after second week is reflecting the impaired insulin sens-
itivity during pregnancy and could be mediated, at least partially by
NR4A.
In summary, our data demonstrate that: a) NR4A subfamily
(Nur77, Nurr1 and Nor-1) are similarly regulated in WAT; b)
Figure 5 | Analysis of pituitary factors on gWAT NR4A1, NR4A2 and NR4A3 mRNA expression. (A) Effects of thyroid status on gWAT mRNA levels of
NR4A1, NR4A2 and NR4A3 relative to control (Euthyroid). (B) Effects of GH deficiency on gWAT mRNA levels of NR4A1, NR4A2 and NR4A3
relative to control (Lewis Expression of indicated mRNAs was normalized to that of HPRT and the resultant value for each group was normalized to
expression of the target gene in control. Data are expressed as mean 6 SEM (n 5 7–8 animals per group). *p , 0.05; **p , 0.01 versus controls.
www.nature.com/scientificreports
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WAT Nur77, Nurr1 and Nor-1 expression are regulated by nutri-
tional status and food composition in a leptin-independent manner;
c) WAT Nur77, Nurr1 and Nor-1 expression is increased throughout
postnatal development and this up-regulation is mediated by
testosterone and oestrogens; d) WAT NR4A mRNA levels are regu-
lated by changes in the pituitary function, specifically thyroid hor-
mone deficiency decreases all NR4A receptors and GH deficiency
decreases only Nur77; e) WAT NR4A mRNA levels are increased in
the first week of gestation and decrease after the second week. The
results obtained in this report show the regulation of mRNA levels in
white adipose tissue in vivo. We were unsuccessful in measuring
protein levels for Nr4a gene products, since antibodies failed to detect
endogenous levels of the different NR4A isoforms. Because protein
levels not always mimic its mRNA levels, further studies analyzing
protein expression will be necessary for a better understanding of the
molecular mechanisms regulating.
Methods
Animals. Male and female Sprague–Dawley rats, male C57BL6J mice and male ob/ob
mice were housed in air-conditioned rooms (22–24uC) under a 12:12 h light/dark
cycle and fed standard rat chow and water ad libitum.
After the experiment, rats and mice were sacrificed and all tissues were rapidly
explanted and snap frozen on dry ice. Tissues were collected and frozen at 280uC
until they were used. The animal procedures were conducted according to the prin-
ciples approved by the Animal Care Research Bioethics Committee form University
of Santiago de Compostela.
Effects of food deprivation on NUR77, NURR1 and NOR-1 expression in gWAT.
This study examined the effects of fasting in 10-weeks-old male Sprague-Dawley rats
in NR4A family mRNA expression. The control group was fed ad libitum, two groups
were deprived of food for 24 h, while another group was fasted for 24 h and refed for
24 h (n 5 8/group)38,39. All animals had free access to tap water (n 5 8/group).
Effects of ICV leptin administration on NUR77, NURR1 and NOR-1 expression
in gWAT. For this study, surgery was performed in wt mice and ob/ob mice. Brain
cannula was placed stereotaxically into the lateral ventricle as previously
described39,40. A catheter tube was placed, and after 5 days of recovery, mice were
injected with 3 mg of leptin and sacrificed at 6 hours.
Effect of chronic food restriction on NUR77, NURR1 and NOR-1 expression in
gWAT. This study examined the effects of chronic food restriction on gWAT NR4A
family mRNA expression in 10-week-old male rats. Rats were randomly assigned
to one of the two dietary groups on day 1 as previously describe41,42: rats were either
fed ad libitum or food restricted to 30% of the amount of food consumed by ad
libitum fed rats the day before. Rats were sacrificed after 8, 12 and 21 days on the
restricted diet (n 5 8/group).
Effect of high fat diet on NUR77, NURR1 and NOR-1 expression in gWAT. Eight-
week-old male Sprague- Dawley rats were fed standard chow (standard diet) or high
fat diet (Research Diets 12451; 45% fat, 4,73 kcal/g, Research Diets, New Brunswick,
NJ) during 8 weeks.
Effect of gestation on NUR77, NURR1 and NOR-1 expression in gWAT. The
gestational effects were studied on Sprague-Dawley rats according to the method
described elsewhere42,43. Female rats were mated on the days of proestrus at
approximately 10-weeks-old. The first day of pregnancy were documented by the
presence of a vaginal plug with sperm after mating. gWAT was collected from
pregnant rats sacrificed on days 12, 16, 19 and 21 of gestation. Non-pregnant rats were
used as control.
Influence of age and gender on NUR77, NURR1 and NOR-1 expression. To
analyse the effect of age and gender, male and female Sprawe-Dawley rats were
studied at the following ages: 25, 45, 60 and 90 day-old as described38,44.
Effect of gonadal hormones on NUR77, NURR1 and NOR-1 expression in gWAT.
In order to analyse the influence of gonadal hormones, adult male and female
Sprague-Dawley rats were bilaterally orchidectomized/gonadectomized (ORX/
GDX), ovarectomized (OVX) or sham operated rats as previously described42,45. Two
weeks after surgery the different groups of rats were sacrificed.
Effect of pituitary axis on NUR77, NURR1 and NOR-1 expression. To elucidate the
effects of the pituitary axis on NR4A family mRNA and protein levels, we performed
the following experiments:
The effect of thyroid status was evaluated as described elsewhere46. Sprague-
Dawley rats were rendered hypothyroid by 3 weeks of treatment with 0.1% amino-
triazole (3-amino-1, 2, 4-triazole; Sigma-Aldrich, St. Louis, MO, USA) in drinking
water; Aminothriazole (AMT) treatment significantly increased plasma thyroid-
stimulating hormone47 levels (control rats: 3.17 6 0.38 ng/mL; amino-triazole–
treated rats: 27.17 6 1.71 ng/mL; p , 0.05), and decreased T3/T4 levels48.
To investigate the effect of growth hormone (GH), spontaneous dwarf rats, a GH-
deficient model, and Lewis wild-type age-matched rats were used and validation of
this model for IGF measurements as described previously46,48.
Figure 6 | Effects of gestation on NR4A1, NR4A2 and NR4A3 mRNA
expression in gWAT. mRNA expression of NR4A1 (A), NR4A2 (B) and
NR4A3 (C) relative to control (control non-pregnant) throughout
gestation. Expression of indicated mRNAs was normalized to that of
HPRT and the resultant value for each group was normalized to expression
of the target gene in control. Data are expressed as mean 6 SEM (n 5 7–8
animals per group). *P , 0.05 versus controls. Data are expressed as mean
6 SEM (n 5 7–8 animals per group). *p , 0.05; **p , 0.01 versus
controls.
www.nature.com/scientificreports
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Leptin levels measurement. Plasma leptin levels were measured by
radioimmunoassay as described previously49,50, using reagents provided in
commercial kits (Rat leptin radioimmunoassay, Linco Research Inc., St Charles, MO,
USA). The sensitivity was 0.5 ng/ml, the coefficients of intra-assay and of inter-assay
variance were 3.3 and 4.8%, respectively.
Quantitative real-time PCR (qRT-PCR) analysis. RNA was extracted using TrizolH
reagent (Invitrogen) according to the manufacturer’s instructions. For each RT
reaction and cDNA synthesis were used 0,5 mg of total RNA.
The total volume to RT reaction was of 30 ml in the subsequent proportions: 10 ml
sample, 6 ml buffer (5X first strand buffer; Invitrogen)(250 mM Tris-HCl, pH 8.3,
375 mM KCl, 15 mM MgCl2, 50 nM DDT), 6 ml dNTPs mixture 20 mM(dTTp,
dCTp, dGTp & dATp) (Invitrogen), 1,5 ml MgCl2 50 mM (Invitrogen), 0.17 ml pri-
mers (Random primers, Invitrogen), 0.25 ml RNAsa (RNAseOUTH, 40 U/ml
Invitrogen), 1 ml m-MLV reversotranscriptase (200 U/ml, Invitrogen) and H2O
DEPC until. All reactions were carried out using the following cycling parameters:
37uC for 1 hour, 42uC for 15 min and 95uC for 5 min. Negative control reactions,
containing all reagents except the sample were used to ensure specificity of the RT
reaction.
For the analysis of gene expression we used real-time reverse-transcription poly-
merase chain reaction (RT-PCR) analyses performed in a fluorescent temperature
cycler (TaqManH; Applied Biosystems; Foster City, CA, USA) following the manu-
facturer’s instructions44,51. Five hundred ng of total RNA were used for each RT
reaction. The PCR cycling conditions included an initial denaturation at 50uC for 10
min followed by 40 cycles at 95uC for 15 sec; 60uC for 1 min. The oligonucleotide
specific primers and probes used were:
HPRT (FW 59-39: AGCCGACCGGTTCTGTCAT; RV:
GGTCATAACCTGGTTCATCATCAC; PB: CGACCCTCAGTCCCAGCGTCGTGA),
NR4A1 rat (FW: CTGTTGCTAGAGTCCGCCTTTC; RV:
CAGGCCTGAGCAGAAGATGAG; PB: CCTCCGCCTGGCCTACCGATCTAA),
NR4A2 rat (FW: GCTGAAGCCATGCCTTGTG; RV:
GCTGTATTCTCCCGAAGAGTGGTA; PB: TCGCCTCAAGGAGCCAGCCCC),
NR4A3 rat, mouse (FW: GAAGGAAGTTGTGCGTACAGATAGTC;
RV:CTCGGACAAGGGCGTTCAT; PB: CCACTACAACAGGAGCCCTCGCAGC)
NR4A1 mouse (FW: TCTGCCTTCCTGGAACTCTTCA; RV:
CAGGCCTGAGCAGAAGATGAG; PB: CCTCCGCCTGGCCTACCGATCTAA),
NR4A2 mouse (FW: GCTGAAGCCATGCCTTGTG; RV:
GCTGTATTCTCCCGAAGAGTGGTA; PB: TCGCCTCAAGGAGCCAGCCCC).
Primer Express 3.0 (Applied Biosystems) program was used to primers design. The
probe contains fluorophore FAM (Fluorescein-6) in 59extreme and TAMRA in 39.
The primers were support from Eurofins MWG Operon.
For the analysis of the data, the input value of the gene of interest was standardized
to the HPRT value for the sample group and was expressed compared with the
average value for the control group.
Statistical analysis. Values are plotted as the mean 6 SEM for each genotype.
Statistical analysis was performed using one-way ANOVA followed by a post hoc
multiple comparison test (Bonferronís test). A p value less than 0.05 was considered
statistically significant.
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